{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.5044","meta":{"versionId":"10","lastUpdated":"2020-12-17T01:00:36.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5044","version":"20201217","name":"SARS Coronavirus 2 IgA, Qualitative and Quantitative","status":"active","date":"2020-12-17T01:00:36-05:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://loinc.org","version":"2.72","concept":[{"code":"94562-6","display":"SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay"},{"code":"94720-0","display":"SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"code":"95427-1","display":"SARS-CoV-2 (COVID-19) IgA Ab [Titer] in Serum or Plasma by Immunofluorescence"}]}]}}